S

Syndax Pharmaceuticals

115 employees

Syndax Pharmaceuticals focuses on developing an HDAC inhibitor for solid tumors and hematological tumors.

Basic info

Industry

biotechnology research

Sectors

Biotechnology
Health Care
Pharmaceutical
Clinical Trials

Date founded

2005

Funding rounds raised

Total raised

$80M

from 23 investors over 23 rounds

S

Syndax Pharmaceuticals raised $30M on January 31, 2020

Investors: Frazier Healthcare Partners and Hercules Capital, Inc.

S

Syndax Pharmaceuticals raised $80M on August 24, 2015

Investors: Jennison Associates LLC, Delos Capital, Forward Ventures, RMI Partners, MPM Capital, Domain Associates and OrbiMed Advisors

S

Syndax Pharmaceuticals raised $27M on August 27, 2013

Investors: MPM Capital, Domain Associates, RMI Partners and Forward Ventures

S

Syndax Pharmaceuticals raised $9M on March 16, 2010

Investors: Forward Ventures, MPM Capital, Avalon Venture, Pappas Ventures and Domain Associates

S

Syndax Pharmaceuticals raised $40M on April 3, 2007

Investors: Domain Associates, Pappas Ventures, MPM Capital, Forward Ventures and Avalon Venture

FAQ